Search for Bayer AG and
    1. November 24, 2014

      Bayer to use IPO funds to cut debt and buy consumer drugs

      Bayer will use the billions it expects to raise from the initial public offering of its plastic business to pay down debt...

    2. November 11, 2014

      Ackman-led team takes 10% stake in Zoetis

      The activist investor Bill Ackman is leading a $2.2bn raid on Zoetis, the animal vaccines and medications business spun off...

    Special Reports

    1. Special Report: Doing Business in Lyon 2013

      Urban renewal is at the heart of ambitions to rise up the rankings in the economic pre...
    2. Health: Emerging Markets

      From the rising scourge of diabetes to the Ebola epidemic, responses around the world ...
    Search more Special Reports on this topic.

    1. October 30, 2014

      Bayer raises guidance as new drugs drive sales

      Bayer’s shift towards life sciences including the acquisition of Merck’s consumer health business has led the German...

    2. October 16, 2014

      Pharma giants face developing market ambitions

      As the pharmaceuticals industry careered towards the edge of its notorious patent cliff over the past decade, there was one...

    3. October 13, 2014

      FT-BC Index: Treasures and grumbles

      It is interesting to see what puts companies right at the top of the index, but also to highlight hidden nuggets elsewhere....

    4. September 19, 2014

      Letter from Lex: ending a relationship

      It has been a week for thinking about break-ups, and not just in Scotland. Over on the west coast of the US there has also...

    5. September 18, 2014

      Bayer: some of the parts

      Break it up, spin it, flog it, float it. Demergers are popular, partly because they are easily done – on paper. Every MBA...

    6. September 18, 2014

      Bayer plans float of plastics business and focus on life sciences

      Bayer is planning to float its plastics business in what would be one of the biggest European initial public offerings for...

    7. July 28, 2014

      Drugmakers juggle non-core assets

      Reckitt Benckiser’s planned spin-off of its pharmaceuticals division adds to a dizzying range of deals in the...

    8. July 28, 2014

      GSK and Reckitt: pharming out

      Well done Reckitt Benckiser and GlaxoSmithKline. But what took you so long? Both have recognised that pharmaceuticals and...

    9. July 10, 2014

      Corporate bond sales hit five-year highs

      Global companies have turned to international debt markets in the first half of 2014 to meet their funding needs, seizing on...

    10. July 6, 2014

      Drugmakers warn on South Korea pricing policy

      International pharmaceutical companies have warned Seoul that they are holding back new medicines from the country’s market,...

    11. June 24, 2014

      Corporate videos put employees in the frame

      Many people use YouTube and Facebook to achieve “15 minutes of fame” in their personal lives by making videos about their...

    12. June 8, 2014

      Japanese drugmakers sit out global M&A party

      Japanese drugmakers have been conspicuous by their absence from the dealmaking bonanza sweeping the sector across Europe and...

    13. May 9, 2014

      Week in Review, May 10

      A round up of some of the week’s most significant corporate events and news stories. Paris keeps pressure on Alstom over...

    14. May 9, 2014

      Letter from Lex: dealing in governance

      Readers, It’s not just tech stocks any more. Shown any sign of weakness and sellers will come after any would-be growth...

    15. May 7, 2014

      Lanxess to raise 10% more capital

      Lanxess is set to issue new shares equivalent to 10 per cent of its equity capital as new chief executive Matthias Zachert...

    16. FT Alphaville

      May 6, 2014

      The Closer

      FURTHER FURTHER READING - Billionaire hedgies made money the old-fasioned way. - A thousand cuts and the last mile problem....

    17. May 6, 2014

      Bayer / Merck: the right price?

      This looks expensive. Any deal done at 21 times historic earnings before interest, tax, depreciation and amortisation...

    18. May 6, 2014

      Bayer acquires Merck’s consumer healthcare business for $14.2bn

      Germany’s Bayer has agreed to buy Merck’s consumer healthcare business for $14.2bn, acquiring brands including Coppertone...

    19. May 1, 2014

      Reckitt Benckiser no longer in talks to buy Merck unit

      Reckitt Benckiser is no longer in talks to buy Merck’s consumer healthcare division, paving the way for a rival to land the...

    20. April 28, 2014

      Bayer expected to focus on life sciences

      A rebound in German conglomerate Bayer’s plastics business has fuelled speculation that the division could be sold as part...

    21. April 28, 2014

      Reckitt and Bayer circle Merck auction of consumer healthcare

      Merck of the US is in the final stages of selling its consumer healthcare unit for close to $14bn, with Reckitt Benckiser...

    22. March 12, 2014

      Bayer: high hopes

      The 2014 targets from Bayer: 5 per cent sales growth; growth in earnings before interest, tax, depreciation and amortisation...

    23. January 26, 2014

      Lanxess chief Heitmann to quit as profits fall

      Lanxess chief executive Axel Heitmann is to stand down after the speciality chemical company’s profits were hit by growing...

    24. December 26, 2013

      Drug groups pin hopes on Iran market potential

      When Pfizer sold a small batch of medicines to Iran last year, the process was painful. The pharmaceutical group needed...

    25. December 19, 2013

      Bayer set to buy Norwegian cancer drugmaker Algeta

      Bayer is set to acquire the Norwegian cancer drug company Algeta after raising its initial cash bid to NKr17.6bn ($2.9bn)....

    26. December 8, 2013

      Change without sour grapes

      When Jörg Reinhardt rejoined Novartis in August to take up his new role as chairman of the Swiss pharmaceutical group, he...

    27. November 26, 2013

      Bayer / Algeta: the piper pays

      In German, a $2.4bn takeover offer means: “We intend to buy you. Please sign here.” In Norwegian, it means: “Let’s talk...

    28. November 26, 2013

      Bayer offers $2.4bn for cancer drug partner Algeta

      Bayer of Germany has launched a bid to take control of Algeta in a deal valuing the Norwegian maker of injectable...

    29. October 22, 2013

      Chemicals: Science views waste in role as raw material of the future

      It sounds like the perfect solution. Bayer, a venerable German chemicals company, has developed a process for using carbon...

    30. September 29, 2013

      Academia should heed industry’s scientific plea

      This year in Washington business school educators and administrators assembled at the National Academy of Sciences to meet...

    31. September 18, 2013

      Lanxess to cut 1,000 jobs amid downturn in motor industry

      Lanxess, the German speciality chemicals company, is set to cut 1,000 jobs by the end of 2015 and reduce management bonuses...

    32. September 13, 2013

      Bayer under investigation in China

      Bayer is being investigated in China over a “potential case of unfair competition”, as foreign pharmaceutical companies...

    33. August 1, 2013

      Inside Business: Handicaps of sector and name fail to check Lanxess

      The ugly duckling of Leverkusen turned this week into the swan of Cologne. Lanxess, a German speciality chemicals company...

    34. June 30, 2013

      The Week Ahead: July 1 – July 7

      • Companies week ahead • Economic Outlook: Manufacturing, exports and labour data give window on the world • See a full...

    35. May 22, 2013

      US doctors paid $1bn by top drug companies

      A dozen leading drug companies paid US doctors a total of more than $1bn last year, according to fresh data revealing the...

    36. May 17, 2013

      Dow to fight $1.2bn in price-fixing damages

      Dow Chemical plans to fight a $1.2bn damages award for price-fixing using a recent antitrust ruling in the Supreme Court, it...

    37. May 15, 2013

      India: Patents and precedents

      Meena, a 45-year-old New Delhi widow with a 10-year-old son, was diagnosed with potentially fatal blood cancer in 2010. To...

    38. May 12, 2013

      Interview: Nigerian entrepreneur Charles Anudu

      Charles Anudu knew by the age of 15 that he wanted to be an entrepreneur, but it would be a decade and half before he...

    Search for Bayer AG and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Lex on whether demerger makes real business sense...
      September 18, 2014

      Lex on whether demerger makes real business sense

    2. Lex on potential bidding war for Schiff between Reckitt and Bayer...
      November 16, 2012

      Lex on potential bidding war for Schiff between Reckitt...